Solve various computational biology and chemistry problems with advanced technologies.
Application of in silico analysis and prediction methods to antibody variable fragment (Fv) regions.
Provide a way to measure the potential immune responses of biologics and biosimilars.
Our AI-driven platform utilizes molecular simulation technologies to provide antibody de novo design.
The analysis of drug targets can reflect which structures of drugs can interact with the target molecules and produce curative effects.
Determine the similarities and differences between different drugs better and reduce the high investment in actual testing.
Network-based methodologies for drug–target interactions (DTI) prediction in silico.
Build a disease-gene-drug network, and evaluate reusable drugs.
The PK/PD modeling is helpful for drug screening and accelerates the process of new drug development.
Tech Trends in Artificial Intelligence What's up, what's down, what lies ahead, only found in MedAI!